Overview Request Sample Pages Request Customization Download PDF
You are viewing: Australia Infusion Pump Market analysis
Part of: Infusion Pump Market (Global)

The Australia Infusion Pump Market was valued at $200.7 Million in 2025 and projected to reach to $299 Million by 2030, representing a compound annual growth rate of 8.3%. Australia's infusion pump market is positioned for robust growth, expanding from USD 200.7 million in 2025 to USD 299.0 million by 2030 at an 8.3% CAGR, outpacing the global growth rate of 7.4%.

Australia Infusion Pump Market Trends and Insights

  • This growth trajectory reflects Australia's advancing healthcare infrastructure and increasing demand for precision drug delivery systems across hospitals, clinics, and home care settings.
  • Australia's aging population and rising prevalence of chronic diseases are driving adoption of infusion pump technologies that enable safer, more accurate medication administration. The Australian infusion pump market benefits from strong regulatory frameworks, high healthcare spending, and widespread adoption of digital health solutions.
  • Between 2025 and 2030, Australia is expected to see accelerated deployment of smart infusion pumps with integrated safety features and connectivity capabilities.
  • Healthcare providers across Australia are investing in next-generation infusion systems to reduce medication errors and improve patient outcomes, positioning the country as a key growth market within the Asia Pacific region..

Key Market Statistics

  • CAGR (2025-2030) 8.3% CAGR
  • Market Size, 2025 ~USD 200.7 Million
  • Forecast, 2030 ~USD 299 Million
  • Country Australia

Australia Infusion Pump Market Overview

Market Valuation :

Australia's infusion pump market is valued at USD 200.7 million in 2025, with strong growth momentum driven by healthcare modernization and increased adoption of advanced drug delivery technologies across the nation.

Aging Population Demand :

Australia's rapidly aging demographic is driving increased demand for precision infusion systems in chronic disease management, palliative care, and hospital settings, supporting sustained market expansion.

Healthcare Infrastructure Growth :

Expansion of Australian healthcare facilities, including regional hospitals and home care services, is creating new opportunities for infusion pump deployment and market penetration across diverse care settings.

Regulatory Environment :

Australia's stringent TGA (Therapeutic Goods Administration) standards ensure high-quality infusion pump products, fostering consumer confidence and supporting premium market positioning for compliant manufacturers.

Australia Infusion Pump Market Dynamics

  • This acceleration is driven by Australia's aging population requiring advanced chronic disease management, increased healthcare spending, and growing adoption of home-based infusion therapies.
  • The market benefits from strong regulatory frameworks and healthcare infrastructure investments across metropolitan and regional areas. Key growth catalysts include rising prevalence of diabetes, cancer, and cardiovascular diseases requiring precision drug delivery, coupled with technological advancements in smart infusion systems.
  • Australian hospitals and aged care facilities are increasingly investing in automated infusion solutions to improve patient outcomes and operational efficiency.
  • Continued government healthcare initiatives and private sector expansion will sustain market momentum through 2030..

Related Ecosystem

Drug Delivery Devices

Top Technologies
  • Disposable Autoinjectors
  • Reusable Autoinjectors
  • Insulin Pumps
  • Pen Injectors
  • Transdermal Patches
Top Companies
  • Novo nordisk a/s
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Medtronic plc
  • Nipro Corporation

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • Australia's infusion pump market is valued at USD 200.7 million in 2025 and is forecast to reach USD 299.0 million by 2030, growing at a CAGR of 8.3%.
      • Australia's aging demographic and rising chronic disease burden are primary drivers of infusion pump adoption across healthcare facilities.
      • Smart infusion pumps with integrated safety features and digital connectivity are becoming increasingly prevalent in Australia's healthcare system.
      • Australia's robust regulatory environment and high healthcare expenditure support sustained market growth and technology innovation through 2030.

      Infusion Pump Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment SPECIALTY INFUSION PUMPS (Technology)
      Forecast Period 2025–2030
      Growth Rate CAGR of 7.4% from 2025 to 2030
      Largest Segment ACCESSORIES AND CONSUMABLES (Product)
      Market Size Base Year (Billions) ~USD 19.8 (2025)
      Revenue Forecast (Billions) ~USD 28.3 (2030)
      Segments Covered Product, Type, Technology, Mode, Mode Of Administration, End User, Application

      Australia Infusion Pump Market Report Segmentation

      7 segment dimensions are covered across the global market.

      By Product

      • Accessories And Consumables
      • Devices

      By Type

      • Ambulatory Infusion Pump Dedicated Disposables
      • Ambulatory Infusion Pumps
      • Cannulas
      • Chemotherapy Pumps
      • Dedicated Accessories And Consumables
      • Disposable Infusion Pumps
      • Enteral Infusion Pump Dedicated Disposables
      • Enteral Infusion Pumps
      • Implantable Infusion Pump Dedicated Disposables
      • Implantable Infusion Pumps
      • Infusion Catheters
      • Insulin Infusion Pump Dedicated Disposables
      • Insulin Infusion Pumps
      • Iv/Administration Sets
      • Needless Connectors
      • Non-Dedicated Accessories And Consumables
      • Other Non-Dedicated Accessories And Consumables
      • Patient Controlled Analgesia Infusion Pumps
      • Pca Pump Dedicated Disposables
      • Syringe Infusion Pump Dedicated Disposables
      • Syringe Infusion Pumps
      • Tubing And Extension Sets
      • Valves
      • Volumetric Infusion Pumps
      • Volumetric Pump Dedicated Disposables

      By Technology

      • Specialty Infusion Pumps
      • Traditional Infusion Pumps

      By Mode

      • Portable Infusion Pumps
      • Stationary Infusion Pumps

      By Mode Of Administration

      • Enteral
      • Epidural
      • Intrathecal
      • Intravenous
      • Subcutaneous

      By End User

      • Academic & Research Institutes
      • Ambulatory Care Settings
      • Home Care Settings
      • Hospital
      • Hospitals
      • Oncology Centers
      • Other End Users

      By Application

      • Analgesia/Pain Management
      • Chemotherapy/ Oncology
      • Chemotherapy/Oncology
      • Diabetes Management
      • Gastroenterology
      • Hematology
      • Other Applications
      • Pediatrics / Neonatology
      • Pediatrics/ Neonatology
      • Pediatrics/Neonatology

      Target Audience

      • Medical Device Manufacturers : Infusion pump manufacturers need Australia-specific market data to assess market entry opportunities, competitive positioning, and growth potential in this high-CAGR segment with strong regulatory frameworks and aging population demographics.
      • Healthcare Facility Operators : Hospital administrators, aged care providers, and clinic operators require market insights to justify capital investments in infusion pump technology, understand adoption trends, and optimize procurement strategies for Australian healthcare settings.
      • Investment & Private Equity Firms : Investors evaluating healthcare technology opportunities in Australia need detailed market sizing, growth projections, and competitive dynamics to identify acquisition targets and assess portfolio company expansion potential in the infusion pump sector.
      • Healthcare Consultants & Advisors : Management consultants and healthcare advisors require Australia-specific market data to support client strategy development, market entry planning, and competitive benchmarking for infusion pump manufacturers and healthcare providers.
      • Government & Policy Makers : Australian health department officials and policy makers need market intelligence to inform healthcare infrastructure planning, reimbursement policies, and technology adoption initiatives aligned with aging population care requirements.

      Key Companies in the Australia Infusion Pump Market

      CompanyHQOwnershipStrongest segments
      NOVO NORDISK A/SDenmarkPublic CompanyDiabetes care (insulin, GLP-1 injectables, related therapies),Obesity therapies (injectable and oral GLP-1 for weight management),Rare Disease (rare blood and endocrine disorders, HRT),
      CONSORT MEDICALUnited KingdomPrivate CompanyInhalation devices (MDIs, DPIs, respiratory platforms),Injectable and autoinjector devices,Nasal and other specialty delivery devices,
      CONVATECUnited KingdomPublic CompanyAdvanced Wound Care,Ostomy Care,Continence and Critical Care,
      FRESENIUS SE & CO KGAAGermanyPublic CompanyInjectable generics & IV fluids,Clinical nutrition (enteral & parenteral),Biopharmaceuticals & biosimilars,
      HENRY SCHEINUnited StatesPublic CompanyGlobal Distribution and Value-Added Services,Global Specialty Products,Global Technology,
      PFIZERIndiaPublic CompanyInternal medicine (cardio, respiratory, gastro, neuroscience, women’s health, pain, nutrition),Vaccines,Anti-infectives and injectables,
      ZOLL MEDICAL CORPORATIONUnited StatesPrivate CompanyDefibrillators and monitors (hospital and EMS),Automated external defibrillators (public access and basic EMS),LifeVest and wearable defibrillation,
      WILO SEGermanyPrivate CompanyBuilding Services Residential,Building Services Commercial,Original Equipment Manufacturers (OEM),
      ANGIODYNAMICS, INCUnited StatesPublic CompanyMed Device – Peripheral Access and Drainage (angiographic catheters, guidewires, drainage catheters, micropuncture kits, ports),Med Tech – Thrombus Management (AlphaVac, AngioVac, thrombolytic catheters),Med Tech – Atherectomy (Auryon Atherectomy System),
      MALLINCKRODT PLCIrelandPrivate CompanyAutoimmune and rare disease therapies,Immunotherapy and neonatal respiratory critical care,Analgesics,
      BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyMedical Essentials (syringes, needles, vascular access, sharps, basic disposables),Connected Care (infusion therapy, IV medication safety, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
      BAXTER INTERNATIONAL, INC.United StatesPublic CompanyMedical Products & Therapies,Healthcare Systems & Technologies,Pharmaceuticals,
      MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
      ICU MEDICAL, INC.United StatesPublic CompanyInfusion pumps and medication safety software,Vascular access and needlefree connectors,IV solutions and diluents,
      TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
      NIPROJapanPublic CompanyDialysis products and services,Injection and infusion products, hospital and diabetic products,Pharmaceuticals (generic and kit products),
      AVANOS MEDICAL, INC.United StatesPublic CompanyDigestive health (Mic-Key, Corpak, NeoMed),Non-opioid surgical pain and recovery (ON-Q, ambIT, Game Ready),Interventional pain (COOLIEF, Trident, Esentec RFA),
      INSULET CORPORATIONUnited StatesPublic CompanyOmnipod 5 AID system,Omnipod DASH and legacy Omnipod systems,Drug-delivery pods (e.g., Neulasta Onpro),
      TANDEM DIABETES CARE, INC.United StatesPublic Companyt:slim X2 insulin pump systems,Tandem Mobi and automated insulin delivery systems,Cartridges and infusion sets,
      JMS CO., LTD.United StatesPublic CompanyU.S. Retail Coffee,U.S. Retail Frozen Handheld and Spreads,U.S. Retail Pet Foods,
      MOOG, INC.United StatesPublic CompanySpace and Defense,Military Aircraft,Commercial Aircraft,
      TELEFLEX INCORPORATEDUnited StatesPublic CompanyVascular access & emergency medicine (Arrow, EZ-IO, QuikClot),Interventional cardiology & peripheral (GuideLiner, Turnpike, MANTA, DCBs, stents),Surgical products (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),

      NOVO NORDISK A/S

      Novo Nordisk A/S is a Danish pharmaceutical company founded in 1923 with 67,900 employees. Operating as a public company, it is a major player in the global healthcare industry.

      CONSORT MEDICAL

      Consort Medical is a United Kingdom-based private company established in 1938 with 2,000 employees. The company operates in the medical device and pharmaceutical sectors.

      CONVATEC

      ConvaTec is a United Kingdom public company founded in 1978 specializing in medical devices and healthcare products. The company serves patients and healthcare providers globally.

      FRESENIUS SE & CO KGAA

      Fresenius SE & Co. KGaA is a German public company founded in 1912 with 177,783 employees. It is a leading global healthcare company providing dialysis, hospital care, and pharmaceutical products.

      HENRY SCHEIN

      Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a major distributor of healthcare products and services to dental, medical, and veterinary markets.

      PFIZER

      Pfizer India is a public company established in 1950 with 1,244 employees. The company operates as part of the global Pfizer pharmaceutical organization in the Indian market.

      ZOLL MEDICAL CORPORATION

      ZOLL Medical Corporation is a United States-based private company founded in 1980 with 1,908 employees. The company specializes in emergency medical devices and software solutions.

      WILO SE

      Wilo SE is a German private company founded in 1872 with 8,442 employees. The company is a leading manufacturer of pumps and pump systems for heating, cooling, and water management.

      ANGIODYNAMICS, INC

      AngioDynamics, Inc. is a United States-based public company founded in 1988 with 632 employees. The company develops and manufactures minimally invasive medical devices for vascular access and oncology.

      MALLINCKRODT PLC

      Mallinckrodt PLC is an Ireland-based private company founded in 1867 with 2,687 employees. The company operates in the specialty pharmaceutical and medical device sectors.

      BECTON, DICKINSON AND COMPANY

      Becton, Dickinson and Company is a United States public company founded in 1897 with 72,000 employees. It is a global medical technology company providing medical devices, laboratory equipment, and diagnostic products.

      BAXTER INTERNATIONAL, INC.

      Baxter International, Inc. is a United States-based public company founded in 1931 with 37,500 employees. The company develops and manufactures healthcare products including IV solutions, infusion systems, and renal care products.

      MEDTRONIC

      Medtronic is a public company headquartered in Ireland and founded in 1949 with 95,000 employees. It is a global leader in medical technology providing devices and therapies for chronic diseases.

      ICU MEDICAL, INC.

      ICU Medical, Inc. is a United States-based public company founded in 1984 with 13,000 employees. The company manufactures and distributes medical devices for critical care and oncology applications.

      TERUMO CORPORATION

      Terumo Corporation is a Japanese public company founded in 1921 with 30,591 employees. The company is a global medical device manufacturer specializing in cardiovascular, transfusion, and cellular therapy products.

      NIPRO

      Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company manufactures and distributes medical devices, pharmaceuticals, and healthcare products globally.

      AVANOS MEDICAL, INC.

      Avanos Medical, Inc. is a United States-based public company founded in 2014 with 2,287 employees. The company develops and markets medical devices for pain management and patient monitoring.

      INSULET CORPORATION

      Insulet Corporation is a United States public company founded in 2000 with 5,400 employees. The company manufactures and distributes insulin infusion pumps and continuous glucose monitoring systems.

      TANDEM DIABETES CARE, INC.

      Tandem Diabetes Care, Inc. is a United States-based public company founded in 2006 with 2,500 employees. The company develops and commercializes insulin delivery and diabetes management products.

      JMS CO., LTD.

      JMS Co., Ltd. is a United States-based public company founded in 1897 with 8,000 employees. The company operates in the medical device and healthcare products sector.

      MOOG, INC.

      Moog, Inc. is a United States-based public company founded in 1951 with 13,500 employees. The company manufactures precision motion and control products for aerospace, defense, and medical applications.

      TELEFLEX INCORPORATED

      Teleflex Incorporated is a United States public company founded in 1943 with 15,500 employees. The company designs and manufactures medical devices for critical care, surgery, and interventional procedures.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise valuation data for Australia's infusion pump market (USD 200.7M in 2025) with verified 8.3% CAGR projections through 2030, enabling confident investment and expansion decisions in this high-growth segment.
      • Demographic-Driven Opportunity Analysis : Understand how Australia's aging population directly impacts infusion pump demand across hospitals, clinics, and home care settings, with detailed insights into patient demographics and care setting requirements specific to the Australian market.
      • Competitive Landscape Intelligence : Gain Australia-specific competitive positioning data, regulatory compliance requirements (TGA standards), and market entry strategies tailored to the Australian healthcare ecosystem and reimbursement landscape.
      • Regional Growth Drivers : Identify key growth catalysts unique to Australia including healthcare infrastructure expansion, government funding initiatives, and regional penetration opportunities across metropolitan and rural healthcare facilities.
      • Strategic Planning & Forecasting : Leverage comprehensive 5-year forecasts and market segmentation data specific to Australia to develop targeted go-to-market strategies, resource allocation plans, and revenue projections for infusion pump products and services.

      Frequently asked questions

      What is the current size of Australia's infusion pump market?

      Australia's infusion pump market is valued at USD 200.7 million in 2025 and is expected to grow to USD 299.0 million by 2030.

      What is the projected growth rate for Australia's infusion pump market?

      Australia's infusion pump market is projected to grow at a CAGR of 8.3% from 2025 to 2030.

      What factors are driving growth in Australia's infusion pump market?

      Key drivers include Australia's aging population, rising prevalence of chronic diseases, advanced healthcare infrastructure, and increasing adoption of smart infusion pump technologies with safety features.

      Which healthcare settings in Australia are adopting infusion pumps?

      Infusion pumps are being adopted across Australia's hospitals, clinics, ambulatory care centers, and home care settings as part of precision drug delivery initiatives.

      How does Australia's infusion pump market compare to the Asia Pacific region?

      Australia represents a significant market within Asia Pacific, driven by high healthcare spending, strong regulatory standards, and early adoption of advanced medical technologies compared to regional peers.

      RESEARCH METHODOLOGY

      This study extensively used both primary and secondary sources. The research involved studying various factors affecting the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

      Secondary Research

      This research study involved the usage of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the infusion pump market. It was also used to identify key players in the market and classify and segment the industry based on trends to the most detailed level. Additionally, significant developments related to market and technology perspectives were noted. A database of the primary industry leaders was also created using secondary research.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the infusion pump market. Primary sources from the demand side include healthcare professionals from hospitals, nursing care facilities, long-term health centers, and ambulatory surgery centers.

      A breakdown of the primary respondents is provided below:

      Infusion Pump Market

      Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

      Note 2: Other designations include sales, marketing, and product managers.

      Note 3: Tiers are defined based on a company’s total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The total size of the infusion pump market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

      Infusion Pump Market

      Data Triangulation

      After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

      Market Definition

      The infusion pump encompasses the global spectrum of advanced medical devices designed to deliver precise volumes of fluids—ranging from medications and nutrients to various therapeutic solutions—directly into a patient's vascular system. These devices are integral to contemporary healthcare, ensuring a meticulous administration of treatments that demand consistent dosing regimens, such as chemotherapy, pain management, insulin therapy, and hydration protocols. Infusion pumps are engineered for high programmability and versatility, capable of delivering both micro and macro volumes at continuous or intermittent rates based on clinical requirements. They can be categorized by functionality into several types: volumetric pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, ambulatory infusion pumps, insulin pumps, and implantable infusion pumps. In contrast to traditional manual delivery methods, infusion pumps enhance accuracy, safety, and automation, making them indispensable in critical care environments and for effective chronic disease management. Their technological advancements facilitate complex infusion scenarios and improve patient outcomes through reliable dosing accuracy and reduced medication errors.

      Stakeholders

      • Medical device manufacturers and distributors
      • Infusion pump manufacturers
      • Infusion pump and related instrument manufacturing companies
      • Suppliers and distributors of infusion pumps
      • Hospitals and ambulatory surgery centers
      • Clinics
      • Home healthcare agencies
      • Research and consulting firms
      • Contract manufacturing organizations
      • Venture capitalists

      Report Objectives

      • To define, describe, segment, and forecast the infusion pump market by type, mode of administration, application, end user, and region
      • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall infusion pump market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the infusion pump market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players in the infusion pump market and comprehensively analyze their core competencies and market shares
      • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

       

      Get the Full Infusion Pump Market Report

      Full forecast, segment splits, and company analysis for all Infusion Pump Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status